Americans for Ibogaine Logo
Donate Now Give Monthly

Responsible Advocacy Means Honest Communication

Americans for Ibogaine believes credible advocacy requires transparency about risks as well as benefits. Ibogaine is a powerful pharmacological compound — not a supplement meant for casual therapy. Its potential to help must be weighed against its real medical risks, which is precisely why we advocate for FDA-supervised, medically controlled access rather than unregulated use.

Known Risks &
Contraindications

Ibogaine affects the heart's electrical system and can prolong the QT interval, which may lead to dangerous cardiac arrhythmias in some patients. This is the most significant medical risk associated with ibogaine and the primary reason medical screening and supervision are essential.

Ibogaine may be contraindicated for individuals with pre-existing heart conditions or prolonged QT interval, certain liver conditions, some psychiatric conditions, or concurrent use of specific medications (particularly those affecting heart rhythm).

Ibogaine treatment involves an extended period (often 12-36 hours) of altered consciousness requiring continuous medical monitoring. Physical side effects may include nausea, ataxia (impaired coordination), and tremors. Psychological effects can be intense and require professional integration support.

The Case for Medical Supervision

The risks associated with ibogaine are manageable — but only in proper medical settings. This means:

Comprehensive cardiac evaluation (EKG), liver function tests, full medical history review, and medication assessment.

Continuous cardiac monitoring, medical staff on-site, and emergency equipment available.

Integration therapy, follow-up assessments, and ongoing care coordination.

This is why Americans for Ibogaine advocates for ibogaine access through the FDA approval pathway. Proper regulation ensures that safety protocols are standardized, providers are trained, and patients are protected.

Our Position on Safety

We will never minimize the risks of ibogaine therapy. We believe:

  • No one should undergo ibogaine treatment without thorough medical screening
  • Treatment should only occur under qualified medical supervision with cardiac monitoring
  • The FDA approval process — while lengthy — is the only responsible pathway to ensuring ibogaine is administered safely at scale
  • Unregulated access puts patients at unnecessary risk
  • Our advocacy for ibogaine is advocacy for safe ibogaine — nothing less.
Read Our Code of Ethics
or Find Treatment Resources

JOIN US

Join thousands of advocates, researchers, and supporters receiving monthly updates on ibogaine research, state legislation, and ways to make a difference.